Main Street completes $6.5 million new portfolio investment

NewsGuard 100/100 Score

Main Street Capital Corporation (NYSE: MAIN) ("Main Street") announced today that it has completed a new portfolio investment totaling $6.5 million.

Main Street's investment in SYNEO, LLC ("SYNEO" or the "Company") facilitated the merger of Technical Innovations, LLC ("TI"), an existing Main Street portfolio company, and ASG Medical Systems, LLC ("ASG"). The SYNEO investment consists of $5.5 million in first lien secured debt and a $1.0 million direct equity investment. TI designs and manufactures manual, semi-automated, pneumatic and computer numerically controlled (CNC) machines and tools used by medical device manufacturers to place holes in catheters and for tissue cutting applications. TI's product mix includes razor sharp drills, punches and related machines. Main Street made its initial investment in TI during 2002. ASG is a leader in the automation of catheter and guidewire manufacturing. ASG's tubing and guidewire cutters, feeders, testers and custom automation machines provide high production capacity and consistent outgoing quality while reducing manufacturing costs. The Company believes that the combination of TI and ASG will allow the two companies to better serve their customers through a broadened service capability and product offering. The current management of TI and ASG will continue in their current operating roles and serve in senior executive roles with SYNEO, and will also collectively retain a majority equity interest in SYNEO as part of the transaction.

SOURCE Main Street Capital Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Absorbance 96 Automate revealed: The world’s first on-deck plate reader for laboratory automation